ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2783

Hydroxychloroquine Blood Levels and Risk of Thrombotic Events in Systemic Lupus Erythematous

Maximlian Konig1, Jessica Li 1 and Michelle Petri 1, 1Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: hydroxychloroquine and thrombosis, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Session Title: 5T093: SLE – Clinical V: Emerging Knowledge of Current Treatments (2780–2785)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: The antimalarial drug hydroxychloroquine (HCQ) has a primary role in the treatment of systemic lupus erythematous (SLE). Beyond its pleiotropic immunomodulatory effects on TLR and type I interferon signaling, HCQ use has been found to be protective for thrombosis in SLE. Optimal dosing of HCQ in SLE is unknown. The longitudinal measurement of HCQ blood levels may provide an opportunity to individualize weight-based dosing strategies and reduce risk of toxicity. We examined the association of HCQ blood levels with thrombotic events in a longitudinal SLE cohort.

Methods: Patients with no HCQ level measured prior to the thrombosis were excluded. 812 SLE patients were included: 93% female, 43% African-American, 46% Caucasian. HCQ blood levels were quantified by liquid chromatography-tandem mass spectrometry. Mean HCQ blood levels (± SD) over all cohort visits prior to occurrence of thrombosis were calculated for each patient. Thromboses were defined as venous (DVT/PE or other venous) or arterial thrombosis (stroke, myocardial infarction, digital gangrene or other arterial).

Results: Thrombosis had occurred during prospective follow up in 44 patients (5.4%), venous in 3.0% and arterial in 2.5%. Lupus anticoagulant was strongly associated with a history of any thrombosis (OR 3.25, P< 0.0001), venous thrombosis (OR 3.53, P< 0.0001), and arterial thrombosis (OR 3.08, P< 0.0001). A prospective analysis (Table 1) shows that for any thrombosis and for venous thrombosis, the HCQ blood level was significantly lower. Higher prescribed doses of HCQ (as opposed to HCQ blood levels) were also associated with decreased odds of any thrombosis and also of venous thrombosis (Table 2) in a separate cross-sectional analysis (OR 0.88, P=0.04 and OR 0.83, P=0.009, respectively for each 1 mg/kg increase in prescribed HCQ).

Conclusion: HCQ blood levels are inversely associated with risk of any thrombosis and of venous thrombosis in patients with SLE in a prospective analysis. Reduction of HCQ dosing, as suggested by the American Academy of Ophthalmologists, could reduce or eliminate the benefit of hydroxychloroquine to prevent thrombosis.


ACR 2019 Abstract HCQ and Thrombosis-Konig v3-Table1

Table 1. Prospective Analysis of Risk of Thrombosis and Mean Hydroxychloroquine Blood Levels


ACR 2019 Abstract HCQ and Thrombosis-Konig v3-Table2

Table 2. Cross-Sectional Analysis of Risk of Thrombosis and Mean Prescribed Hydroxychloroquine Dose


Disclosure: M. Konig, None; J. Li, None; M. Petri, Eli Lilly and Company, 5, Exagen, 2, 5.

To cite this abstract in AMA style:

Konig M, Li J, Petri M. Hydroxychloroquine Blood Levels and Risk of Thrombotic Events in Systemic Lupus Erythematous [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/hydroxychloroquine-blood-levels-and-risk-of-thrombotic-events-in-systemic-lupus-erythematous/. Accessed July 4, 2022.
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hydroxychloroquine-blood-levels-and-risk-of-thrombotic-events-in-systemic-lupus-erythematous/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies